Can serum GAD65 antibody levels predict neurological disease or cancer?

Henning K. Olberg; Geir Egil Eide; Christian A. Vedeler

doi:https://doi.org/10.1016/j.jneuroim.2019.577025

doi.org/10.1016/j.jneuroim.2019.577025

Can serum GAD65 antibody levels predict neurological disease or cancer?

,

,

Journal of Neuroimmunology3.30

Volume: 336, Pages: 577025 - 577025

Published: Nov 1, 2019

Abstract

The clinical relevance of antibodies that bind to glutamic acid decarboxylase 65 (GAD65) is controversial regarding diagnostic utility in screening for neurological disease or cancer. We did a retrospective study of 3152 GAD65 antibody-positive patients to examine whether analysis of the antibody levels could predict neurological disease or cancer. Serum GAD65 antibody levels were not associated with any of the following groups: neurological...